MEGA GENOMICS (06667) announced a net profit of 41.974 million yuan in 2025 after adjustment, a year-on-year increase of 6.9%.

MEGA GENOMICS (06667) announced its performance in 2025, achieving an operating income of approximately 247 million yuan, a year-on-year increase of 50.5%. Net profit was 27.021 million yuan, a year-on-year decrease of 40%; adjusted net profit was 41.974 million yuan, a year-on-year increase of 6.9%. The announcement states that the increase in income is mainly due to the continuous expansion of product categories, the improvement of product matrix layout, and the optimization of the overall business structure by the group, with multiple measures working together to effectively drive the steady increase in overall revenue scale. The decrease in net profit is mainly due to several one-time expenses and comprehensive factors affecting the impairment of financial assets. During the reporting period, the company made provisions for impairment of financial assets of 9.5 million yuan, while the net amount of impairment reversal of financial assets in the same period last year was 7.3 million yuan; in addition, the group incurred one-time expenses related to the resumption of trading of 5.5 million yuan during the reporting period, and a total donation of 1.9 million yuan for the Hong Kong Tai Po fire and other public welfare projects. If the impact of the above-mentioned changes in the impairment of financial assets and one-time related expenses is excluded, the group's adjusted net profit increased compared to the same period last year, and the main business profit remained steadily improving.